Long-term retention rate of pramipexole in the treatment of Parkinson's disease

被引：3
|
作者：
Keranen, Tapani [1 ,2 ]
Tuhkasaari, Mervi [1 ]
Kuusisto, Hanna [2 ]
机构：
[1] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
[2] Tampere Univ Hosp, Div Neurol & Rehabil, Tampere, Finland
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 65卷 / 09期
关键词：
Outcome; Parkinson's disease; Pramipexole; Retention rate; EFFICACY; SAFETY;
D O I：
10.1007/s00228-009-0661-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：955 / 956
页数：2
相关论文
共 50 条
  • [1] Long-term retention rate of pramipexole in the treatment of Parkinson’s disease
    Tapani Keränen
    Mervi Tuhkasaari
    Hanna Kuusisto
    [J]. European Journal of Clinical Pharmacology, 2009, 65 : 955 - 956
  • [2] Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
    Maurits E. L. Arbouw
    Kris L. L. Movig
    Jeroen P. P. van Vugt
    Toine C. G. Egberts
    [J]. European Journal of Clinical Pharmacology, 2009, 65 : 957 - 957
  • [3] Reply: long-term retention rate of pramipexole in the treatment of Parkinson's disease
    Arbouw, Maurits E. L.
    Movig, Kris L. L.
    van Vugt, Jeroen P. P.
    Egberts, Toine C. G.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (09) : 957 - 957
  • [4] Long-term retention rate of entacapone in the treatment of Parkinson's disease
    Keraenen, T.
    Tuhkasaari, M.
    Kuusisto, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : E30 - E30
  • [5] The long-term safety and efficacy of pramipexole in advanced Parkinson's disease
    Weiner, WJ
    Factor, SA
    Jankovic, J
    Hauser, RA
    Tetrud, JW
    Waters, CH
    Shulman, LM
    Glassman, PM
    Beck, B
    Paume, D
    Doyle, C
    [J]. PARKINSONISM & RELATED DISORDERS, 2001, 7 (02) : 115 - 120
  • [6] Long-term safety and efficacy of pramipexole in early Parkinson's disease
    Bressman, SB
    Shulman, LM
    Tanner, CM
    Rajput, AH
    Shannon, KM
    Wright, E
    [J]. NEUROLOGY, 1999, 52 (06) : A261 - A261
  • [7] The long-term safety and efficacy of pramipexole in advanced Parkinson's disease
    Weiner, WJ
    Factor, SA
    Jankovic, J
    Hauser, RA
    Tetrud, JW
    Waters, CH
    Shulman, LM
    Glassman, PM
    Beck, B
    Paume, D
    Doyle, C
    [J]. NEUROLOGY, 1999, 52 (06) : A261 - A262
  • [8] Long-term improvement of wearing off in Parkinson's disease (PD) with pramipexole
    Jaskolka, J
    Burkholder, J
    Bain, A
    Kish, S
    Meier, D
    Rhein, IA
    Guttman, M
    [J]. NEUROLOGY, 1999, 52 (06) : A408 - A408
  • [9] Predictors of long-term efficacy pramipexole therapy in patients with Parkinson's disease
    Smolentseva, IG
    Levin, OS
    Tserensodnom, B
    Fedorova, NV
    Dokadina, LV
    [J]. MOVEMENT DISORDERS, 2004, 19 : S233 - S233
  • [10] Long-term medical treatment for Parkinson’s disease
    John M. Bertoni
    Jose-Luis Prendes
    Pamela Sprenkle
    [J]. Current Treatment Options in Neurology, 2001, 3 (6) : 495 - 506
12345